Bellevue Funds (Lux) - Diversified Healthcare U2 CHF - Accumulating
LU2441707812
Bellevue Funds (Lux) - Diversified Healthcare U2 CHF - Accumulating/ LU2441707812 /
NAV6/13/2025 |
Chg.-0.8600 |
Type of yield |
Investment Focus |
Investment company |
109.8100CHF |
-0.78% |
reinvestment |
Equity
Worldwide
|
Waystone M.Co.(Lux) ▶ |
Investment strategy
The fund aims to achieve capital growth in the long term by investing in global healthcare securites.
The Fund invests at least two thirds of the net assets of Bellevue Diversified Healthcare in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term "healthcare", the healthcare sector includes companies from the pharmaceutical, medical technology, biotechnology and related sectors. This includes in particular companies that create, develop, utilise, market and/or sell processes, methods, technologies, products or services used for diagnostic and therapeutic purposes in humans and animals, as well as entities primarily engaged in investing in or financing such companies. In addition, the Company may invest up to one third of the net assets of Bellevue Diversified Healthcare in carefully selected shares and other equity securities from other companies that have their registered office or carry out the majority of their economic activity in recognised countries, or in fixed-income or floating-rate securities, convertible bonds and bonds with warrants from issuers from recognised countries.
Investment goal
The fund aims to achieve capital growth in the long term by investing in global healthcare securites.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Health / Pharma |
Benchmark: |
MSCI World Healthcare |
Business year start: |
7/1 |
Last Distribution: |
- |
Depository bank: |
CACEIS Investor Services Bank |
Fund domicile: |
Luxembourg |
Distribution permission: |
Austria, Germany, Switzerland, Czech Republic |
Fund manager: |
Dr.TerenceMcManus |
Fund volume: |
22.68 mill.
USD
|
Launch date: |
3/31/2022 |
Investment focus: |
- |
Conditions
Issue surcharge: |
5.00% |
Max. Administration Fee: |
0.60% |
Minimum investment: |
50,000,000.00 CHF |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
Waystone M.Co.(Lux) |
Address: |
19, rue de Bitbourg, 1273, Luxemburg |
Country: |
Luxembourg |
Internet: |
www.waystone.com
|
Assets
Stocks |
|
98.96% |
Others |
|
1.04% |
Countries
United States of America |
|
65.49% |
Switzerland |
|
9.73% |
United Kingdom |
|
6.19% |
France |
|
4.43% |
Japan |
|
3.82% |
Denmark |
|
3.41% |
Ireland |
|
1.48% |
China |
|
0.89% |
Israel |
|
0.56% |
Netherlands |
|
0.54% |
Hong Kong, SAR of China |
|
0.43% |
Australia |
|
0.37% |
Finland |
|
0.36% |
Belgium |
|
0.32% |
Italy |
|
0.32% |
Others |
|
1.66% |
Branches
Pharma/Biotechnology |
|
54.37% |
Healthcare Appliances |
|
22.24% |
Healthcare Services |
|
15.78% |
Pharma, Wholesale |
|
3.00% |
Gesundheitswesen/ Informationstechnologie |
|
1.88% |
Grooming Products |
|
1.70% |
Others |
|
1.03% |